Central Middlesex Hospital is in the centre of the Park Royal business estate, on the border of two London boroughs, Brent and Ealing. It is managed by the London North West University Healthcare NHS Trust.

There are 214 beds in Central Middlesex Hospital.

During the past decade, Central Middlesex Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Middlesex Hospital" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Smith & Nephew Orthopaedics AG" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "InDex Pharmaceuticals" with 1 trials sponsored and "King's College Hospital NHS Trust" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Middlesex Hospital" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator and "King's College London" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Central Middlesex Hospital" are "Arthritis" (2 trials), "Joint Diseases" (2 trials), "Knee" (2 trials), "Macular Edema" (2 trials) and "Musculoskeletal Diseases" (2 trials). Many other conditions were trialed in "Central Middlesex Hospital" in a lesser frequency.

Most popular intervention types in "Central Middlesex Hospital" are "Drug" (5 trials), "Device" (4 trials), "Procedure" (4 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (2 trials), "Faricimab" (2 trials), "NAVIO/CORI Surgical System" (2 trials), "Non-robotic conventional instrumentation" (2 trials) and "Sham Procedure" (2 trials). Other intervention names were less common.

The vast majority of trials in "Central Middlesex Hospital" are 9 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Central Middlesex Hospital". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Central Middlesex Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Central Middlesex Hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".